202 related articles for article (PubMed ID: 32593420)
21. Association between augmented renal clearance, antibiotic exposure and clinical outcome in critically ill septic patients receiving high doses of β-lactams administered by continuous infusion: a prospective observational study.
Carrié C; Petit L; d'Houdain N; Sauvage N; Cottenceau V; Lafitte M; Foumenteze C; Hisz Q; Menu D; Legeron R; Breilh D; Sztark F
Int J Antimicrob Agents; 2018 Mar; 51(3):443-449. PubMed ID: 29180280
[TBL] [Abstract][Full Text] [Related]
22. Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?
Roberts JA; Roberts MS; Robertson TA; Dalley AJ; Lipman J
Crit Care Med; 2009 Mar; 37(3):926-33. PubMed ID: 19237898
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients.
Veiga RP; Paiva JA
Crit Care; 2018 Sep; 22(1):233. PubMed ID: 30244674
[TBL] [Abstract][Full Text] [Related]
24. β-lactam antibiotic concentrations during continuous renal replacement therapy.
Beumier M; Casu GS; Hites M; Seyler L; Cotton F; Vincent JL; Jacobs F; Taccone FS
Crit Care; 2014 May; 18(3):R105. PubMed ID: 24886826
[TBL] [Abstract][Full Text] [Related]
25. Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. A Meta-analysis of Individual Patient Data from Randomized Trials.
Roberts JA; Abdul-Aziz MH; Davis JS; Dulhunty JM; Cotta MO; Myburgh J; Bellomo R; Lipman J
Am J Respir Crit Care Med; 2016 Sep; 194(6):681-91. PubMed ID: 26974879
[TBL] [Abstract][Full Text] [Related]
26. Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams.
Gonçalves-Pereira J; Póvoa P
Crit Care; 2011; 15(5):R206. PubMed ID: 21914174
[TBL] [Abstract][Full Text] [Related]
27. β-Lactam pharmacodynamics in Gram-negative bloodstream infections in the critically ill.
Wong G; Taccone F; Villois P; Scheetz MH; Rhodes NJ; Briscoe S; McWhinney B; Nunez-Nunez M; Ungerer J; Lipman J; Roberts JA
J Antimicrob Chemother; 2020 Feb; 75(2):429-433. PubMed ID: 31665353
[TBL] [Abstract][Full Text] [Related]
28. Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT).
Abdulla A; Dijkstra A; Hunfeld NGM; Endeman H; Bahmany S; Ewoldt TMJ; Muller AE; van Gelder T; Gommers D; Koch BCP
Crit Care; 2020 Sep; 24(1):558. PubMed ID: 32933574
[TBL] [Abstract][Full Text] [Related]
29. Empirical models for dosage optimization of four beta-lactams in critically ill septic patients based on therapeutic drug monitoring of amikacin.
Delattre IK; Musuamba FT; Verbeeck RK; Dugernier T; Spapen H; Laterre PF; Wittebole X; Cumps J; Taccone FS; Vincent JL; Jacobs F; Wallemacq PE
Clin Biochem; 2010 Apr; 43(6):589-98. PubMed ID: 20036226
[TBL] [Abstract][Full Text] [Related]
30. Repeated Piperacillin-Tazobactam Plasma Concentration Measurements in Severely Obese Versus Nonobese Critically Ill Septic Patients and the Risk of Under- and Overdosing.
Jung B; Mahul M; Breilh D; Legeron R; Signe J; Jean-Pierre H; Uhlemann AC; Molinari N; Jaber S
Crit Care Med; 2017 May; 45(5):e470-e478. PubMed ID: 28240688
[TBL] [Abstract][Full Text] [Related]
31. Population pharmacokinetics and Monte Carlo dosing simulations of meropenem during the early phase of severe sepsis and septic shock in critically ill patients in intensive care units.
Jaruratanasirikul S; Thengyai S; Wongpoowarak W; Wattanavijitkul T; Tangkitwanitjaroen K; Sukarnjanaset W; Jullangkoon M; Samaeng M
Antimicrob Agents Chemother; 2015; 59(6):2995-3001. PubMed ID: 25753628
[TBL] [Abstract][Full Text] [Related]
32. Elevated β-lactam concentrations associated with neurological deterioration in ICU septic patients.
Beumier M; Casu GS; Hites M; Wolff F; Cotton F; Vincent JL; Jacobs F; Taccone FS
Minerva Anestesiol; 2015 May; 81(5):497-506. PubMed ID: 25220556
[TBL] [Abstract][Full Text] [Related]
33. The ANTIBIOPERF study: a nationwide cross-sectional survey about practices for β-lactam administration and therapeutic drug monitoring among critically ill patients in France.
Charmillon A; Novy E; Agrinier N; Leone M; Kimmoun A; Levy B; Demoré B; Dellamonica J; Pulcini C
Clin Microbiol Infect; 2016 Jul; 22(7):625-31. PubMed ID: 27145210
[TBL] [Abstract][Full Text] [Related]
34. Current guidelines for the treatment of severe pneumonia and sepsis.
Bodmann KF
Chemotherapy; 2005 Aug; 51(5):227-33. PubMed ID: 16103664
[TBL] [Abstract][Full Text] [Related]
35. Stability of 10 Beta-Lactam Antibiotics in Human Plasma at Different Storage Conditions.
Bahmany S; Ewoldt TMJ; Abdulla A; Koch BCP
Ther Drug Monit; 2023 Oct; 45(5):606-615. PubMed ID: 37199408
[TBL] [Abstract][Full Text] [Related]
36. Rapid quantification of six β-lactams to optimize dosage regimens in severely septic patients.
Wolff F; Deprez G; Seyler L; Taccone F; Hites M; Gulbis B; Vincent JL; Jacobs F; Cotton F
Talanta; 2013 Jan; 103():153-60. PubMed ID: 23200371
[TBL] [Abstract][Full Text] [Related]
37. A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II study.
Dulhunty JM; Roberts JA; Davis JS; Webb SA; Bellomo R; Gomersall C; Shirwadkar C; Eastwood GM; Myburgh J; Paterson DL; Starr T; Udy AA; Paul SK; Lipman J; ;
Crit Care Resusc; 2013 Sep; 15(3):179-85. PubMed ID: 23944203
[TBL] [Abstract][Full Text] [Related]
38. Demonstrating Feasibility of an Opportunistic Sampling Approach for Pharmacokinetic Studies of β-Lactam Antibiotics in Critically Ill Children.
Tang Girdwood SC; Tang PH; Murphy ME; Chamberlain AR; Benken LA; Jones RL; Stoneman EM; Kaplan JM; Vinks AA
J Clin Pharmacol; 2021 Apr; 61(4):565-573. PubMed ID: 33111331
[TBL] [Abstract][Full Text] [Related]
39. Key Challenges in Providing Effective Antibiotic Therapy for Critically Ill Patients with Bacterial Sepsis and Septic Shock.
Landersdorfer CB; Nation RL
Clin Pharmacol Ther; 2021 Apr; 109(4):892-904. PubMed ID: 33570163
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic drug monitoring of β-lactam antibiotics in the critically ill: direct measurement of unbound drug concentrations to achieve appropriate drug exposures.
Wong G; Briscoe S; McWhinney B; Ally M; Ungerer J; Lipman J; Roberts JA
J Antimicrob Chemother; 2018 Nov; 73(11):3087-3094. PubMed ID: 30137377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
